201 related articles for article (PubMed ID: 3335690)
1. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.
McKenna WJ; Franklin RC; Nihoyannopoulos P; Robinson KC; Deanfield JE
J Am Coll Cardiol; 1988 Jan; 11(1):147-53. PubMed ID: 3335690
[TBL] [Abstract][Full Text] [Related]
2. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
McKenna WJ; Kleinebenne A
Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmia and prognosis in hypertrophic cardiomyopathy.
McKenna WJ
Eur Heart J; 1983 Nov; 4 Suppl F():225-34. PubMed ID: 6686539
[TBL] [Abstract][Full Text] [Related]
4. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
McKenna WJ; England D; Doi YL; Deanfield JE; Oakley C; Goodwin JF
Br Heart J; 1981 Aug; 46(2):168-72. PubMed ID: 7196768
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.
Maron BJ; Savage DD; Wolfson JK; Epstein SE
Am J Cardiol; 1981 Aug; 48(2):252-7. PubMed ID: 7196685
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients.
Fananapazir L; Tracy CM; Leon MB; Winkler JB; Cannon RO; Bonow RO; Maron BJ; Epstein SE
Circulation; 1989 Nov; 80(5):1259-68. PubMed ID: 2805263
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.
Spirito P; Rapezzi C; Autore C; Bruzzi P; Bellone P; Ortolani P; Fragola PV; Chiarella F; Zoni-Berisso M; Branzi A
Circulation; 1994 Dec; 90(6):2743-7. PubMed ID: 7994816
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmias in hypertrophic cardiomyopathy.
Kuck KH
Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2706-13. PubMed ID: 9358518
[TBL] [Abstract][Full Text] [Related]
9. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy.
Kowey PR; Eisenberg R; Engel TR
N Engl J Med; 1984 Jun; 310(24):1566-9. PubMed ID: 6539421
[TBL] [Abstract][Full Text] [Related]
10. Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study.
Newman H; Sugrue D; Oakley CM; Goodwin JF; McKenna WJ
J Am Coll Cardiol; 1985 May; 5(5):1064-74. PubMed ID: 4039343
[TBL] [Abstract][Full Text] [Related]
11. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope.
Kuck KH; Kunze KP; Schlüter M; Nienaber CA; Costard A
Eur Heart J; 1988 Feb; 9(2):177-85. PubMed ID: 3280318
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.
Savage DD; Seides SF; Maron BJ; Myers DJ; Epstein SE
Circulation; 1979 May; 59(5):866-75. PubMed ID: 154981
[TBL] [Abstract][Full Text] [Related]
13. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death.
Watson RM; Schwartz JL; Maron BJ; Tucker E; Rosing DR; Josephson ME
J Am Coll Cardiol; 1987 Oct; 10(4):761-74. PubMed ID: 3655144
[TBL] [Abstract][Full Text] [Related]
14. [Ambulatory ECG in cardiomyopathies].
Mestroni L; Miani D; Neri R; Di Lenarda A; Camerini F
G Ital Cardiol; 1987 Dec; 17(12):1139-44. PubMed ID: 3503812
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death.
Medeiros Pde T; Martinelli Filho M; Arteaga E; Costa R; Siqueira S; Mady C; Piegas LS; Ramires JA
Arq Bras Cardiol; 2006 Nov; 87(5):649-57. PubMed ID: 17221043
[TBL] [Abstract][Full Text] [Related]
16. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyopathies and their role in sudden death.
Brandenburg RO
J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):185B-189B. PubMed ID: 3158692
[TBL] [Abstract][Full Text] [Related]
18. [Arrhythmias of primary hypertrophic cardiomyopathy].
Babuty D; Fauchier L; Nguyen D; Giraudeau C; Marie O; Fauchier JP; Cosnay P
Arch Mal Coeur Vaiss; 2003 Dec; 96 Spec No 7():7-15. PubMed ID: 15272516
[TBL] [Abstract][Full Text] [Related]
19. Failure of amiodarone to prevent ventricular fibrillation (sudden death) in hypertrophic cardiomyopathy.
Mercereau D; Kubac G; Klinke WP
Can J Cardiol; 1989 Mar; 5(2):77-80. PubMed ID: 2706577
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF
Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
